Biomerieux Sustainability Profile
bioMérieux, a global leader in in vitro diagnostics, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1963, the company has consistently innovated in the fields of microbiology and molecular biology, achieving significant milestones such as the development of the first automated microbiology system. Specialising in diagnostic solutions for infectious diseases, bioMérieux offers a range of unique products, including rapid tests and automated systems that enhance laboratory efficiency and accuracy. Their commitment to quality and innovation has solidified their position as a trusted partner in healthcare, with notable achievements in improving patient outcomes through timely diagnostics. With a strong focus on research and development, bioMérieux continues to lead the way in advancing diagnostic technologies worldwide.
DitchCarbon Score
How does Biomerieux's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biomerieux's score of 76 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biomerieux's reported carbon emissions
In 2024, bioMérieux reported total greenhouse gas emissions of approximately 1.183 billion kg CO2e, comprising 22 million kg CO2e from Scope 1, 34 million kg CO2e from Scope 2, and about 1.127 billion kg CO2e from Scope 3 emissions. The company has set ambitious targets to reduce its carbon footprint, aiming for a 50% reduction in Scope 1 and Scope 2 emissions by 2030, compared to 2019 levels. Furthermore, bioMérieux is committed to a long-term goal of reducing these emissions by 63% by 2034. The company also plans to reduce its Scope 3 emissions by 35% by 2034, with a focus on engaging suppliers, as 67% of them are expected to have science-based targets by 2026. These commitments align with the Science Based Targets initiative (SBTi) and reflect bioMérieux's dedication to sustainable practices within the healthcare equipment and supplies sector. The emissions data is cascaded from its parent company, bioMérieux S.A., ensuring a comprehensive approach to climate accountability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 31,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 35,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 241,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Biomerieux's Industry?
How Carbon Intensive is Biomerieux's Location?
Biomerieux's Scope 3 Categories Breakdown
Biomerieux's Scope 3 emissions, which increased by 0% last year and increased by approximately 368% since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Biomerieux's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biomerieux has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Biomerieux's sustainability data and climate commitments